Guggenheim Capital LLC Cidara Therapeutics, Inc. Transaction History

Guggenheim Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$3.75 - $6.05 $839,636 - $1.35 Million	-223,903 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$4.0 - $8.15 $483,512 - $985,155	120,878 Added 117.33%	223,903 $895,000
Q4 2017 Feb 14, 2018	SELL	$6.35 - $8.75 $115,709 - $159,442	-18,222 Reduced 15.03%	103,025 $701,000
Q3 2017 Nov 14, 2017	BUY	$5.75 - $8.1 $697,170 - $982,100	121,247	121,247 $982,000

Ticker CDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,075,696
Market Cap $1.63B
Description
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Guggenheim Capital LLC with notifications on news.